Works matching IS 17470277 AND DT 2019 AND VI 94 AND IP 1
Results: 15
A novel interleukin‐13 receptor alpha 2‐targeted hybrid peptide for effective glioblastoma therapy.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1402, doi. 10.1111/cbdd.13517
- By:
- Publication type:
- Article
MolTarPred: A web tool for comprehensive target prediction with reliability estimation.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1390, doi. 10.1111/cbdd.13516
- By:
- Publication type:
- Article
Beyond model interpretability using LDA and decision trees for α‐amylase and α‐glucosidase inhibitor classification studies.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1414, doi. 10.1111/cbdd.13518
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1277, doi. 10.1111/cbdd.13593
- Publication type:
- Article
Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1378, doi. 10.1111/cbdd.13515
- By:
- Publication type:
- Article
Design and optimize N‐substituted EF24 as effective and low toxicity NF‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1368, doi. 10.1111/cbdd.13514
- By:
- Publication type:
- Article
ER alpha selective chromone, isoxazolylchromones, induces ROS‐mediated cell death without autophagy.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1352, doi. 10.1111/cbdd.13510
- By:
- Publication type:
- Article
Synthesis of new bis‐pyrazole linked hydrazides and their in vitro evaluation as antimicrobial and anti‐biofilm agents: A mechanistic role on ergosterol biosynthesis inhibition in Candida albicans.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1339, doi. 10.1111/cbdd.13509
- By:
- Publication type:
- Article
QSAR of clinically important EGFR mutant L858R/T790M pyridinylimidazole inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1306, doi. 10.1111/cbdd.13505
- By:
- Publication type:
- Article
Molecular design of sequence‐minimized, structure‐optimized, and hydrocarbon‐stapled helix–helix interactions in the trimer‐of‐hairpins motif of pediatric pneumonia RSV‐F protein.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1292, doi. 10.1111/cbdd.13501
- By:
- Publication type:
- Article
Synthesis and biological activity of Ub2 derived peptides as potential host‐directed antitubercular therapy.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1330, doi. 10.1111/cbdd.13508
- By:
- Publication type:
- Article
Computational insights into the interaction mechanisms of estrogen‐related receptor alpha with endogenous ligand cholesterol.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1316, doi. 10.1111/cbdd.13506
- By:
- Publication type:
- Article
Retraction.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1422, doi. 10.1111/cbdd.13504
- Publication type:
- Article
Design, synthesis, anti‐mycobacterial and cytotoxic evaluation of C‐4 functionalized 1,8‐naphthalimide‐heterocyclic hydrazide conjugates.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1300, doi. 10.1111/cbdd.13503
- By:
- Publication type:
- Article
Synthesis and antitumor activity of 2‐isocamphanyl thiosemicarbazone derivatives via ROS‐enhanced mitochondrial damage.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 94, n. 1, p. 1281, doi. 10.1111/cbdd.13492
- By:
- Publication type:
- Article